Switch theme
Sign up to access all valuation multiples
Amplitude Surgical is engaged in developing and marketing products for orthopedic surgery. It offers a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities for foot and ankle surgery. The company also provides AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and the E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery.
2011
460
Last FY Revenue $119M
Last FY EBITDA $26.5M
$446M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Amplitude Surgical achieved revenue of $119M and an EBITDA of $26.5M.
Amplitude Surgical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Amplitude Surgical valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $119M | XXX | XXX | XXX |
| Gross Profit | XXX | $94.0M | XXX | XXX | XXX |
| Gross Margin | XXX | 79% | XXX | XXX | XXX |
| EBITDA | XXX | $26.5M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 22% | XXX | XXX | XXX |
| EBIT | XXX | $14.5M | XXX | XXX | XXX |
| EBIT Margin | XXX | 12% | XXX | XXX | XXX |
| Net Profit | XXX | $1.7M | XXX | XXX | XXX |
| Net Margin | XXX | 1% | XXX | XXX | XXX |
| Net Debt | XXX | $86.7M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Amplitude Surgical's stock price is EUR 6 (or $7).
Amplitude Surgical has current market cap of EUR 297M (or $334M), and EV of EUR 397M (or $446M).
See Amplitude Surgical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $446M | $334M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Amplitude Surgical has market cap of $334M and EV of $446M.
Amplitude Surgical's trades at 3.9x EV/Revenue multiple, and 19.0x EV/EBITDA.
Equity research analysts estimate Amplitude Surgical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Amplitude Surgical's P/E ratio is not available.
See valuation multiples for Amplitude Surgical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $334M | XXX | $334M | XXX | XXX | XXX |
| EV (current) | $446M | XXX | $446M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 3.9x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 19.0x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 33.4x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 14.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -30.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAmplitude Surgical's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Amplitude Surgical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Amplitude Surgical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Amplitude Surgical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 13% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 67% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Amplitude Surgical acquired XXX companies to date.
Last acquisition by Amplitude Surgical was XXXXXXXX, XXXXX XXXXX XXXXXX . Amplitude Surgical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Amplitude Surgical founded? | Amplitude Surgical was founded in 2011. |
| Where is Amplitude Surgical headquartered? | Amplitude Surgical is headquartered in France. |
| How many employees does Amplitude Surgical have? | As of today, Amplitude Surgical has 460 employees. |
| Who is the CEO of Amplitude Surgical? | Amplitude Surgical's CEO is Mr. Olivier Jallabert. |
| Is Amplitude Surgical publicy listed? | Yes, Amplitude Surgical is a public company listed on PAR. |
| What is the stock symbol of Amplitude Surgical? | Amplitude Surgical trades under AMPLI ticker. |
| When did Amplitude Surgical go public? | Amplitude Surgical went public in 2015. |
| Who are competitors of Amplitude Surgical? | Similar companies to Amplitude Surgical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Amplitude Surgical? | Amplitude Surgical's current market cap is $334M |
| Is Amplitude Surgical profitable? | Yes, Amplitude Surgical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
